Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection
2016
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Burden of liver diseases in the world
2018 Standout
Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis
2016
The biology and function of fibroblasts in cancer
2016 Standout
The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis
2016
Hepatocellular carcinoma
2012 Standout
Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
2017
Hepatitis B virus infection
2009 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
2016
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
2016
The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma
2016
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
2017
Mini-Nutritional Assessment Predicts Functional Status and Quality of Life of Patients With Hepatocellular Carcinoma in Taiwan
2012
Pyroptosis: mechanisms and diseases
2021 Standout
Role of antiviral treatment for HCC prevention
2014
Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C
2018
Global burden of liver disease: 2023 update
2023 Standout
Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B
2015
A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
2010
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
2007
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
2015
Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
2014
Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
2014
Natural history of hepatitis C
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
2015
Hepatocellular carcinoma
2022 Standout
Hepatocellular Carcinoma
2019 Standout
Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy
2015
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients
2013
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta‐Analysis
2020
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Liver stiffness‐based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy
2016
Works of C.-M. Lee being referenced
A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study
2013
A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice
2011
A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients
2009
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy
2012
Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants
2013
Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study
2017
Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience
2015
Prevalence and Clinical Implications of Hepatitis B Virus Genotypes in Southern Taiwan
2003